As of 4:00pm ET
| -0.47 / -2.41%|
The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 41.50, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +118.42% increase from the last price of 19.00.
The current consensus among 2 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.